title: Early phenotypic and genotypic alterations in submandibular gland oncogenesis in rats.
abstract: The present study evaluates the phenotypic and genotypic changes that take place during early oncogenesis. The submandibular glands of male rats were injected with a 0.5% solution of 9,10-dimethyl-1,2-benzanthracene (DMBA) in acetone. Gland samples were taken at 0, 7, 30 and 150 days post-injection and submitted to histological, biochemical, immunocytochemical and PCR evaluation. Histopathological analysis was performed on hematoxylin-eosin stained slides. Total protein content was assessed by Lowry's method and the protein profile was analyzed by 12% SDS-PAGE. Bcl-2 was demonstrated by silver-enhanced gold immunolabeling. p53 immunolabeling was performed using the streptavidin-biotin system. All the treated animals developed carcinoma-like lesions at 30 and 150 days. Total protein concentration rose significantly (p < 0.05) above control values at 7, 30 and 150 days. The treated glands exhibited positive immunolabeling for p53 in the nuclei of neoplastic cells at 30 and 150 days. Treated glands also showed positive cytoplasmic immunolabeling for Bcl-2, exhibiting statistically significant differences between 7, 30 and 150 days (p = 0.0015), and with controls (p < 0.0001). No p53 mutations were observed whereas a point mutation, C-to-A, of the Bcl-2 gene was detected at 7, 30 and 150 days by PCR amplification. This mutation led to a single aminoacid change (thre --> asn) in the protein molecule. Our results suggest that the early histopathological changes correspond to quantitative and qualitative protein changes. The histopathological, biochemical, immunocytochemical and genetic alterations observed during the course of experimental carcinogenesis in the submandibular gland of the rat could constitute reproducible indices of malignant transformation applicable to human oncogenesis, given the high degree of homology between the oncogenes of mice, rats and human beings.
authors.affiliation: Department of Oral Biology, Faculty of Dentistry, National University of Córdoba, Argentina. brunotto2003@yahoo.com.ar
authors.forename: Mabel
authors.initials: M
authors.lastname: Brunotto
authors.forename: Alicia
authors.initials: A
authors.lastname: Malberti
authors.forename: Ana Maria
authors.initials: AM
authors.lastname: Zárate
authors.forename: José Luis
authors.initials: JL
authors.lastname: Barra
authors.forename: Olga
authors.initials: O
authors.lastname: Calderón
authors.forename: Eugenia
authors.initials: E
authors.lastname: Piñas
authors.forename: Luis
authors.initials: L
authors.lastname: Plavnik
authors.forename: Marta
authors.initials: M
authors.lastname: Crosa
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene; D019943:Amino Acid Substitution; D000704:Analysis of Variance; D000818:Animals; D001216:Asparagine / Q000235:genetics; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D004252:DNA Mutational Analysis; D007124:Immunoenzyme Techniques; D008297:Male; D020125:Mutation, Missense; D017354:Point Mutation; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis / Q000235:genetics*; D051381:Rats; D017208:Rats, Wistar; D013365:Submandibular Gland Neoplasms / Q000139:chemically induced / Q000235:genetics* / Q000378:metabolism; D013912:Threonine / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53; D013912:Threonine; D015127:9,10-Dimethyl-1,2-benzanthracene; D001216:Asparagine